Publications by authors named "Javier Alberto Gomez Gonzalez"
Time in range and mean glucose cut-off points for reduction of fetal outcomes in pregnant women with type 1 diabetes using automated insulin delivery systems.
Diabetes Res Clin Pract
November 2024
Article Synopsis
- This study investigates how time in range (TIRp) and mean glucose levels during pregnancy impact fetal health in women with Type 1 Diabetes (T1D) using automated insulin delivery (AID) systems.* -
- The findings reveal that a TIRp below 59.1% and mean glucose over 133 mg/dL in the second trimester are linked to higher instances of fetal outcomes like large for gestational age (LGA) and hyperbilirubinemia.* -
- It suggests that improving TIRp, especially through the early use of advanced hybrid closed loop (AHCL) systems, could enhance fetal outcomes, although more research is required to solidify these recommendations.*
Background: Evidence regarding the implementation of medium-term strategies in advanced hybrid closed-loop (AHCL) system users is limited. Therefore, this study aimed to describe the efficacy and safety of the AHCL system in patients with type 1 diabetes (T1D) on a six-month follow-up in a virtual diabetes clinic (VDC).
Method: A prospective cohort of adult patients with T1D treated using the AHCL system (Mini Med 780G; Medtronic, Northridge, California) in a VDC follow-up.
Aims: To describe Hybrid closed-loop (HCL) and advanced hybrid closed-loop (AHCL) performance in the hospital setting based on the continuous glucose monitoring (CGM) metrics description.
Methods: This was an observational study from a cohort of patients with T1D using HCL/AHCL with history of hospitalization. CGM metrics were analyzed during the hospital stay.
Determination of time in range associated with HbA1c ≤ 6.5% in Latin American pregnant women diagnosed with type 1 diabetes mellitus using an automated insulin delivery system.
Diabetes Res Clin Pract
June 2023
Aims: To determine the correlation between %TIR and HbA1c in pregnant women with type 1 diabetes mellitus (DM1).
Methods: Diagnostic test study in a prospective cohort of pregnant patients with DM1 using automated insulin delivery system (AID)in Colombia and Chile.
Results: Fifty-two patients were included [mean age 31.